Podium Presentations

MoleculeKeynote Speakers

  • John Weinstein, MD, Ph.D.
    Senior Investigator
    Laboratory of Molecular Pharmacology
    CCR, National Cancer Institute


Genomics, Proteomics and Bioinformatics in Cancer Drug Discovery

  • Emanuel F. Petricoin Ph.D.
    Co-Director, NCI-FDA Clinical Proteomics Program
    Senior Principal Investigator


Clinical Proteomcs: Applications at the Bedside

  • Christoph Hergersberg, Ph.D.
    VP, Research, Discovery Systems
    GE Healthcare Biosciences


On the Road to Personalized Medicine: Seeing is Believing


MoleculePlenary Session Papers

  • Jack Copper
    Neuralware Inc.


Development of a Neural Network-Based Cancer Biomarker Classifier

  • John Ledwith
    Senior Applications Consultant
    Spotfire Corp.


Addressing Common Issues in the Access, Analysis and Publishing of Data and Information

  • Peter S. White, Ph.D.
    Research Assistant Professor
    Department of Pediatrics
    University Of Pennsylvania


Biomedical Text Mining for Disease Knowledge Representation

  • Hai Hu, Ph.D.
    Director of Biomedical Informatics
    Windber Research Institute


A Data Warehouse Solution: Bridging Genomic and Clinical Data

  • James Lyons-Weiler
    Assistant Professor, Department of Pathology
    Center for Oncology Informatics
    University Of Pittsburgh Cancer Institute


Comparative Evaluative Approaches to the Analysis of High-Throughput Genomic and Proteomic Data Streams

  • Jason DeBoe
    Principal and Validation Architect
    Aitheras, LLC


21 CFR Part 11 Compliance and IQOQ/PQ Software and Computer Validation Testing for Regulated Environments

  • Dr. Timothy Block
    Professor and Director
    The Jefferson Center of Thomas Jefferson University


Glycoproteomics of the early detection and treatment of chronic hepatitis

  • Dr. Stephen W. Carper
    UNLV Cancer Research Center
    Director UNLV Cancer Research Center


What Scientists Should Know About Molecular Chaperones

  • Robert Clarke, Ph.D., D.Sc.
    Professor of Oncology, Physiology & Biophysics
    Director, Animal Research Program
    Georgetown University School of Medicine


Molecular Analysis of Endocrine Responsiveness in Breast Cancer

  • Darrell Ellsworth, Ph.D.
    Director, Cardiovascular Disease Research Program
    Windber Research Institute


Comprehensive Allelic Imbalance Studies in Non-Neoplastic Breast Tissues in the CBCP (Clinical Breast Care Project)

  • David Ghosh, Ph.D.
    Institute for Transcriptional Informatics


Transcription Factor Database: A Tool for Development of Computationally Defined Models and Regulatory Networks

·         Arnold Glazier, MD
Drug Innovation and Design, Inc.


The Project for the Prevention and Specific Cure of Metastatic Cancer

  • Dr. Steven J. Gordon and
    Karen Helm
    Brooks Automation, Inc.


Fully Automated and Integrated Platform for Preparing Nanoliter Cycle Sequencing Reaction

  • Roderick V. Jensen
    Brigham and Women's Hospital, Harvard Medical School & Wesleyan University


Hemogenomics: Using DNA Microarrays to Discover Genomic Biomarkers in Blood

  • Dr. Richard A. Leach
    Chief Science Officer
    Teneo Sciences, LLC


Modeling Intermediate Phenotypes from Genetic and Clinical Data Using Exemplar, a Specialized Genetic Algorithm

  • Sau-Mei Leung, Ph.D.
    Principal Applications Scientist
    Clinical Proteomics
    Bruker Daltonics


Integration of Functionalized Magnetic Beads and Pattern Recognition Software for Mass Spectrometry Based Disease Biomarker Discovery and Identification

  • G. Larry Maxwell, MD, FACOG
    Walter Reed Army Medical Center


Microarray Analysis of Endometrial Carcinomas and Mixed Mullerian Tumors Reveals Distinct Gene Expression Profiles Associated with Diffeent Histologic Types of Uterine Cancer

  • Brion Sarachan
    GE Global Research


Computational Systems Biology for Molecular Imaging: An example for Alzheimer's disease

  • Richard Somiari, Ph.D.
    Windber Research Institute


Microarray Analysis of Blood RNA for Breast Disease Classification

·         Grace Wong, Ph.D.
Founder and Chief Scientific Officer
ActoKine Therapeutics


Identification of Radioprotective and Viral Preventive Genes for Biodefense

  • Venkat L. Yeruva and
    Abiodun Elegbede, Ph.D.

    UNLV Cancer Research Center and Chemistry Department
    University of Nevada Las Vegas


Regulation of P53 Expression: A Possible Mechanism for the Apoptosis-Inducing Activity of Natural Products

  • Alison Ziesel and
    Paul W. Wong

    Department of Biological Sciences
    University of Alberta


Metabioanalysis Revisited: Refined Functional Characterisation of Two Normal Tissues

  • C. D. Shriver, MD Col.
    Walter Reed Army Medical Center


A novel CBCP methodology utilizing an Integrated Bio-Medical Informatics and Enabling Technologies (IBET) model to integrate Mammography (Murtha Breast Center and Walter Reed), Missile Defense (SMDC – Huntsville), and 4-Dimensional Ultrasound (G.E.)

  • Mandy Raab, PhD.
    Management Science Associates, Inc.


Use of the Research Gateway for Warehouse Data Access